1Anderson DJ,Michelsohn A.Role of glucocorticoids in the chromaffin-neuron developmental decision.Int J Dev Neurosci,1989,7 (5):475-487.
2Cattaneo E,McKay R.Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor.Nature,1990,347 (6295):762-765.
3Reynolds BA,Weiss S.Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.Science,1992,255 (5052):1707-1710.
5Vescovi AL,Snyder EY.Establishment and properties of neural stem cell clones:plasticity in vitro and in vivo.Brain Pathol,1999,9 (3):569-598.
6Groszer M,Erickson R,Scripture-Adams DD,et al.Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.Science,2001,294 (5549):2186-2189.
7Alexson TO.Hitoshi S,Coles BL,et al.Notch signaling is required to maintain all ncural stem cell populations-irrespective of spatial or temporal niche.Dev Neurosci,2006,28 (1-2):34-48.
8Studer L,Tabar V,McKay RD.Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.Nat Neurosci,1998,1 (4):290-295.
2Bove J,Prou D,Perier C,et al.Toxin-induced models of Parkinson's disease[J].NeuroRx,2005,2(3):484-494.
3Pogarell O,Koch W,Gildehaus FJ,et al.Long-term assessment of striatal dopamine transporters in parkinsonian patients with intrastriatal embryonic mesencephalic grafts[J].Eur J Nucl Med Mol Imaging,2006,1-5.
4Meegalla SK,Plossl K,Kung MP,et al.Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents[J].J Med Chem,1997,40(1):9-15.
5Schillaci O,Pierantozzi M,Filippi L,et al.The effect of levodopa therapy on dopamine transporter SPECT imaging with (123)I-FP-CIT in patients with Parkinson's disease[J].Eur J Nucl Med Mol Imaging,2005,32(12):1452-1456.
6Wang J,Jiang YP,Liu XD,et al.99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor[J].Acta Neurol Scand,2005,112(6):380-385.
7Racette BA,Antenor JA,McGee-Minnich L,et al.[18F]FDOPA PET and clinical features in parkinsonism due to manganism[J].Mov Disord,2005,20(4):492-496.
8Juh R,Kim J,Moon D,Cboe B,et al.Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET[J].Eur J Radiol,2004,51(3):223-233.
9Cochen V,Ribeiro M J,Nguyen JP,et al.Transplantation in Parkinson's disease:PET changes correlate with the amount of grafted tissue[J].Mov Disord,2003,18(8):928-932.
9Bjorklund A, Lindvall 0. Cell replacement therapies for centralnervous system disorders[J]. Nat Neurosci,2000, 3(6): 537-544.
10Murakami T, Fujiraoto Y, Yasunaga Y, et al. Transplanted neuronalprogenitor cells in a peripheral nerve gap promote nerve repair [J].Brain Res, 2003, 974(1/2) : 17-24.
